193 related articles for article (PubMed ID: 30587963)
21. NT-proBNP in Different Patient Groups of COPD: A Systematic Review and Meta-Analysis.
Su X; Lei T; Yu H; Zhang L; Feng Z; Shuai T; Guo H; Liu J
Int J Chron Obstruct Pulmon Dis; 2023; 18():811-825. PubMed ID: 37197601
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of two dosages of canrenone as add-on therapy in hypertensive patients taking ace-inhibitors or angiotensin II receptor blockers and hydrochlorothiazide at maximum dosage in a randomized clinical trial: The ESCAPE-IT trial.
Derosa G; Maffioli P; D'Avino M; Sala C; Mugellini A; Vulpis V; Felis S; Guasti L; Sarzani R; Bestetti A; Vanasia M; Gaudio G;
Cardiovasc Ther; 2017 Feb; 35(1):47-54. PubMed ID: 27860389
[TBL] [Abstract][Full Text] [Related]
23. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD.
Chang CL; Robinson SC; Mills GD; Sullivan GD; Karalus NC; McLachlan JD; Hancox RJ
Thorax; 2011 Sep; 66(9):764-8. PubMed ID: 21474497
[TBL] [Abstract][Full Text] [Related]
24. Decreased CD34+ cell number is correlated with cardiac dysfunction in patients with acute exacerbation of COPD.
Liu Y; Liu X; Lin G; Sun L; Li H; Xie C
Heart Lung Circ; 2014 Sep; 23(9):875-82. PubMed ID: 24875532
[TBL] [Abstract][Full Text] [Related]
25. Predictive value of NT-proBNP in vascular surgery patients with COPD and normal left ventricular systolic function.
van Gestel YR; Goei D; Hoeks SE; Sin DD; Flu WJ; Stam H; Mertens FW; Bax JJ; van Domburg RT; Poldermans D
COPD; 2010 Feb; 7(1):70-5. PubMed ID: 20214466
[TBL] [Abstract][Full Text] [Related]
26. Changes in biomarkers of cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease.
Shafuddin E; Chang CL; Cooray M; Tuffery CM; Hopping SJ; Sullivan GD; Jacobson GA; Hancox RJ
Respir Med; 2018 Dec; 145():192-199. PubMed ID: 30509708
[TBL] [Abstract][Full Text] [Related]
27. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers.
Abroug F; Ouanes-Besbes L; Nciri N; Sellami N; Addad F; Hamda KB; Amor AB; Najjar MF; Knani J
Am J Respir Crit Care Med; 2006 Nov; 174(9):990-6. PubMed ID: 16840745
[TBL] [Abstract][Full Text] [Related]
28. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.
Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL
Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921
[TBL] [Abstract][Full Text] [Related]
29. [The predictive value of plasma N-terminal pro-B-type natriuretic peptide levels in the evaluation of prognosis and the severity of patients with septic shock induced myocardial suppression].
Chen W; Zhao L; Liu P; Sheng B; Zhen J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Jan; 25(1):40-4. PubMed ID: 23611096
[TBL] [Abstract][Full Text] [Related]
30. Time course and prognostic value of plasma levels of N-terminal pro-brain natriuretic peptide in patients after ischemic stroke.
Yip HK; Sun CK; Chang LT; Chen MC; Liou CW
Circ J; 2006 Apr; 70(4):447-52. PubMed ID: 16565563
[TBL] [Abstract][Full Text] [Related]
31. Standardized evaluation of lung congestion during COPD exacerbation better identifies patients at risk of dying.
Høiseth AD; Omland T; Karlsson BD; Brekke PH; Søyseth V
Int J Chron Obstruct Pulmon Dis; 2013; 8():621-9. PubMed ID: 24353412
[TBL] [Abstract][Full Text] [Related]
32. Combination of quantitative capnometry, N-terminal pro-brain natriuretic peptide, and clinical assessment in differentiating acute heart failure from pulmonary disease as cause of acute dyspnea in pre-hospital emergency setting: study of diagnostic accuracy.
Klemen P; Golub M; Grmec S
Croat Med J; 2009 Apr; 50(2):133-42. PubMed ID: 19399946
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
[TBL] [Abstract][Full Text] [Related]
34. Safety and tolerability of fixed-dose irbesartan/hydrochlorothiazide for rapid control of severe hypertension.
Neutel JM; Franklin SS; Bhaumik A; Lapuerta P; Oparil S
Clin Exp Hypertens; 2009 Oct; 31(7):572-84. PubMed ID: 19886855
[TBL] [Abstract][Full Text] [Related]
35. Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure.
Yao C; Wang L; Shi F; Chen R; Li B; Liu W; Feng M; Li S
Int J Med Sci; 2021; 18(7):1592-1599. PubMed ID: 33746575
[No Abstract] [Full Text] [Related]
36. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
[TBL] [Abstract][Full Text] [Related]
37. The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study.
He WF; Jiang L; Chen YY; Liu YH; Chen PY; Duan CY; Zeng LH; Fan HL; Wei XB; Guo W; Chen W; Li J; Li WS; Guo ZQ; Liu ZK; Tan N; Chen JY; He PC
BMC Cardiovasc Disord; 2021 Apr; 21(1):202. PubMed ID: 33882836
[TBL] [Abstract][Full Text] [Related]
38. Combination of lung ultrasound (a comet-tail sign) and N-terminal pro-brain natriuretic peptide in differentiating acute heart failure from chronic obstructive pulmonary disease and asthma as cause of acute dyspnea in prehospital emergency setting.
Prosen G; Klemen P; Štrnad M; Grmec S
Crit Care; 2011; 15(2):R114. PubMed ID: 21492424
[TBL] [Abstract][Full Text] [Related]
39. Quality of life and chronic heart failure therapy guided by natriuretic peptides: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study.
Bhardwaj A; Rehman SU; Mohammed AA; Gaggin HK; Barajas L; Barajas J; Moore SA; Sullivan D; Januzzi JL
Am Heart J; 2012 Nov; 164(5):793-799.e1. PubMed ID: 23137512
[TBL] [Abstract][Full Text] [Related]
40. Lower levels of plasma NT-proBNP are associated with higher prevalence of NASH in patients with biopsy-proven NAFLD.
Qiao ZP; Zheng KI; Zhu PW; Gao F; Ma HL; Li G; Li YY; Targher G; Byrne CD; Zheng MH
Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1820-1825. PubMed ID: 32636124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
